# FDA 483 - Southern California Reproductive Center Medical Group PC - July 08, 2025

Source: https://www.keypedia.com/records/483/southern-california-reproductive-center-medical-group-pc/01c6208b-7214-4f70-a663-afa7c34d31d9

> FDA 483 for Southern California Reproductive Center Medical Group PC on July 08, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Southern California Reproductive Center Medical Group PC
- Inspection Date: 2025-07-08
- Product Type: other
- Office Name: Los Angeles District Office
- Summary: An FDA inspection of Southern California Reproductive Center Medical Group PC, a reproductive fertility center in Beverly Hills, CA, identified significant deficiencies in their HCT/P donor eligibility determinations. The firm was cited for determining donors eligible prior to receiving communicable disease testing results and for deeming donors eligible despite positive responses or unanswered questions on donor risk behavior assessments. These findings indicate a failure to ensure donor safety and compliance with screening protocols.

## Related Officers

- [FDA_PERSONNEL](https://www.keypedia.com/people/maurine-fadlalla/519e6e71-a50a-43b5-b41a-2249ec9afdd5)
- [Celeta S. Coves](https://www.keypedia.com/people/celeta-s-coves/d0f63577-a6e4-4872-b06c-a024188a04ba)

Company: https://www.keypedia.com/companies/southern-california-reproductive-center-medical-group-pc/3d5cd1e3-5943-46a7-97bf-9ae661f32838

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b